Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome

Figure 4

Rituximab urine and peritoneal fluid Rituximab concentrations (a) and Rituximab/creatinine ratios (b), as well as IgG urine and peritoneal fluid concentrations (c), and IgG/creatinine ratios (d) of the second case. Since the second patient performed CAPD with three to four peritoneal fluid bag changes per day, the corresponding effluent bags are numbered in chronological order.

(a)

(b)

(c)

(d)